The present invention provides a pharmaceutical agent or composition containing one or more peptides having the amino acid sequence of SEQ ID NO: 1 or 2, or one or more polynucleotides encoding such a peptide formulated for the treatment and/or prevention of cancer in a subject whose HLA-A antigen is HLA-A0206. Furthermore, the present invention provides a method of inducing CTL and antigen-presenting cells using such peptides, polynucleotides or pharmaceutical agents.本發明提供一藥學試劑或組合物包括具有一或多個序列辨識號：1或2之胺基酸序列的胜肽或一或多個編碼出此胜肽的多核苷酸，其配製成用來在HLA-A抗原為HLA-A0206之個體中之癌症的治療及/或預防。此外，本發明提供一使用此胜肽、多核苷酸或藥學試劑誘導細胞毒殺性T淋巴球與抗原呈現細胞的方法。
